Non-Executive Alternate Director Appointment Perth, Australia, 15th August 2016: Phylogica Limited (ASX: PYC) announces that Dr Rohan Hockings has been appointed as an alternate non-executive director of the Company for Dr Bernard Hockings.

Dr. Rohan Hockings currently manages a special purpose acquisition fund within the health care sector. Prior to undertaking this role he has worked in a global management consulting firm, within the equity capital markets team at a national law firm and as a medical practitioner. He has a strong interest in both venture capital and private equity and the role of each in the delivery of better health outcomes.

For further information, please contact:

Ms Stephanie Unwin Tel: +61 8 9286 1219

About Phylogica

Phylogica Limited (ASX: PYC) is a biotechnology company based in Perth, Australia with a world-class drug discovery platform harnessing the rich biodiversity of nature to discover novel peptide therapeutics from the most structurally diverse libraries available. The Company listed on the ASX in 2005 as a spin out from the Telethon Kids Institute (Perth, Australia) and the Fox Chase Cancer Centre (Philadelphia, USA). The Company's drug discovery platform is based on its proprietary Phylomer® libraries containing over 400 billion unique natural peptides, which have been optimised by evolutionary selection to adopt stable drug-like structures. Phylogica offers fully integrated drug discovery services to the pharmaceutical industry utilising its Phylomer® libraries and proprietary screening technologies in exchange for licence fees, milestones and royalties. Partners from discovery alliances within the last 5 years include Roche, MedImmune, Pfizer, Janssen, Cubist Pharmaceuticals and Genentech.

Tel: +61 8 9384 3284 | Fax: +61 8 9284 3801

www.phylogica.com

Phylogica Ltd

ABN 48 098 391 961

Phylogica Limited published this content on 16 August 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 16 August 2016 07:15:03 UTC.

Original documenthttp://phylogica.com/media/articles/Investors---ASX-Announcements/20160816-Alternate-Director-Appointment-1581/1581981.pdf

Public permalinkhttp://www.publicnow.com/view/50D1C6D08F6A35625946E42369399915D60B31AD